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Abstract
Objective To investigate muscle stiffness in patients with idiopathic inflammatory myopathies (IIM) using shear wave
elastography (SWE) and to correlate the results with muscle strength and MRI features of myositis.
Materials and methods Muscle shear wave velocity (SWV) was measured in 23 active IIM patients (13 females, mean
age 50.4 ± 16.1 years) and 23 matched healthy controls (13 females, mean age 50.7 ± 16.2 years). The investigated
muscles included the vastus lateralis (VL), rectus femoris (RF), vastus medialis (VM) vastus intermedius (VI), biceps
femoris (BF), semitendinosus (ST), semimembranosus (SM) and the biceps brachii (BB) scanned during relaxed resting
and passive stretching positions. Participants performed multiple tests to evaluate their muscle strength. IIM patients had
a thigh MRI to assess degrees of oedema, fatty infiltration and atrophy.
Results In the resting position, IIM patients had a 12.9–22.2% significantly lower SWV (p < 0.05) for the quadriceps and
hamstrings, but not BB. There was no difference during passive stretching. The SWV for VL, VI and BF showed
moderate correlations with the muscle strength tests ranging from r = 0.47 to r = 0.70 (all p < 0.05). Lower SWV was
associated with greater MRI scores of oedema (p = 0.001) and atrophy (p = 0.006). However, SWV did not correlate with
fatty infiltration (r < 0.3; p = 0.28), creatine kinase (r = 0.28; p = 0.19) or disease duration (r = 0.26; p = 0.24).
Conclusion Shear wave elastography may detect abnormal reduced thigh stiffness in IIM patients. SWE measurements were
significantly associated withmuscle weakness andMRI signs of oedema and atrophy. Future research should investigate this new
technology for monitoring disease activity.
Keywords Shear wave elastography . Elastography .Muscle . Myositis . Ultrasound
Introduction
Idiopathic inflammatory myopathies (IIM) are a group of sys-
temic autoimmune inflammatory muscle disorders
characterised by muscle weakness, inflammation and structur-
al changes [1]. The early identification of these patients is
important as they may often have a poor prognosis and quality
of life [2]. Although clinical history and physical examination
remain an important aspect of disease assessment, other
methods are often required to improve diagnostic certainty.
However, such additional assessment methods have several
limitations; invasiveness (muscle biopsy), poor sensitivity
and specificity (serology for muscle enzymes and electromy-
ography) or cost and availability (MRI) [3].
Shear wave elastography (SWE) is a relatively new
ultrasound-based technique that has shown promise for the
investigation of musculoskeletal disorders such as
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tendinopathy [4–6], muscle spasticity [7, 8] and Duchenne
muscular dystrophy [9, 10]. However, relatively little work
has focused on muscle. In contrast to the older type of
sonoelastography known as strain elastography, SWE has
the advantage of providing a quantitative measure of tissue
stiffness. A methodology for evaluating SWE in normal mus-
cle has recently been published [11, 12]. We hypothesize that
SWE could potentially be helpful for the investigation of mus-
cles of patients with IIM, as the presence of inflammatory cells
and exudate, thickened capillaries, peri-fascicular atrophy and
myofiber necrosis [13] may result in an alteration of the me-
chanical properties of the tissue.
There are limited published data evaluating muscle elastic-
ity in patients with IIM. A previous study used magnetic res-
onance elastography (MRE) [14] and reported a significantly
decreased muscle stiffness. In contrast, strain elastography
studies [15–17] reported increased muscle stiffness [16] and
correlations with muscle enzymes [15] and echogenicity [17].
However, these studies are difficult to compare owing to their
varying design and methodologies. All lacked any quantifica-
tion of intrinsic muscle elasticity and comparison with a
healthy control group. The quantitative characteristic of mus-
cle elasticity in IIM is not well understood.
The primary objective of this studywas to establish the face
validity of muscle SWE by examining the quantitative char-
acteristics of muscle elasticity in IIM patients compared with
healthy controls. The secondary objective was to investigate
the criterion validity of muscle SWE by correlating it with
MRI-reported features of muscle oedema, atrophy and fatty
infiltration, and with measures of muscle strength, serum cre-
atine kinase level and disease duration.
Materials and methods
Study design
The study was conducted prospectively as a case–control
study. It was approved by the local research ethics committee
and all participants provided written informed consent.
Recruitment began in May 2017 and ended in July 2018.
Myositis patients were recruited from the outpatient rheuma-
tology clinics and inpatient wards at Leeds Teaching Hospitals
Trust. Sex and age frequency-matched healthy controls
(matching the number of patients within categories defined
by sex and 5-year age bands) were recruited from the
University of Leeds and the Leeds Teaching Hospitals Trust
and via advertisements on social media. No formal sample
size/power calculations were carried out owing to a lack of
available data. However, to estimate parameters for powering
future clinical trials, published rules of thumb recommend
between 12 and 30 subjects per group of interest [18, 19].
Inclusion/exclusion criteria
For IIM patients, we recruited adult patients with an
established diagnosis of adult IIM according to previously
described criteria [20, 21]. Additionally, we only included
patients with active disease who presented demonstrable mus-
cle weakness (determined subjectively by a qualified physi-
cian or quantitively by a manual muscle test–8 score < 125/
150) and at least two abnormal measures from the following:
1. Elevation of serum creatine kinase (CK) at a minimum
level of 1.3 times the upper limit of normal
2. Patient global visual analogue scale (VAS) score >
20 mm/100 mm
3. Physician global VAS score > 20 mm/100 mm [22]
Patients were excluded if they had a history of spinal disease
or neuropathy, or any contraindication to MRI. For healthy
controls, we recruited asymptomatic adults (aged > 18 years)
with no previous history of muscle disorders, arthritis or neu-
ropathy. None of the participants was currently on HMG-CoA
reductase inhibitors (statins).
Demographic and clinical information
Basic information was collected, including age, sex, BMI,
alcohol consumption, smoking and global VAS score.
Additionally, subtype of myositis, disease duration and cur-
rent medications were recorded for IIM patients. The latest
CK level reported within the last month was documented.
Shear wave elastography
The SWE system employed was the Aixplorer (Supersonic
Imagine, Aix-en-Provence, France) system using the
SuperLinear™ SL10-2 MHz probe, which has demonstrated
substantial reliability in muscle SWE [12]. The muscles inves-
tigated were the four quadriceps (vastus lateralis [VL], rectus
femoris [RF], vastus medialis [VM] and vastus intermedius
VI]), the three hamstrings (biceps femoris [BF],
semitendinosus [ST] and semimembranosus [SM]) and the
biceps brachii (BB) of the most symptomatic side in patients
and the dominant side in controls. These muscles were chosen
as proximal lower and upper limb muscles, which are known
to be commonly affected in IIM [20]. Positioning was as fol-
lows: resting supine on a flat bed with knees on full extension
(rested quadriceps); elbow flexed at 90° with the forearm rest-
ed on the body and hand in supination (biceps brachii); prone
on a flat bed with the knees flexed at 90° and rested on a wall
(hamstrings). The quadriceps were also tested under passive
stretching with the participants seated while the hips and
knees were flexed at 90° without touching the floor. This
was tested to evaluate if IIM muscle stiffness behaves
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differently under the passive load acted upon by the limb
weight. Participants were instructed to relax their muscles in
all positions and were rested supine for 5 min before scanning.
Two-dimensional SWE acquisitions were repeated three
times per muscle and recorded as shear wave velocity
(SWV) in units of metres per second (m/s). The probe was
oriented along the muscle fibres and placed on top of the skin
with a minimal load while ensuring no external pressure could
deform the tissues and affect the measurements. The operator
was blinded to the MRI and muscle assessment results.
Muscle assessment
All participants performed four muscle assessment tests. First,
handgrip strength was assessed using the Jamar Plus+® elec-
tronic hand dynamometer (Lafayette Instrument Company,
Lafayette, LA, USA) using established protocols [23]. Next,
participants performed the expanded timed get-up-and-go test
(ETGUGT) to assess essential functional tasks such as stand-
ing, balancing and walking [24].
The 30-s chair stand test (CST) was performed afterwards
to test lower body strength and endurance, which has good
responsiveness and construct validity in IIM [25, 26]. Lastly,
isokinetic knee extension/flexion strength was tested using the
Biodex system 4 (IRPS Mediquipe, UK). Participants per-
formed three sets of maximum effort concentric knee exten-
sions and flexions at an angular velocity of 60°/se to calculate
the peak torque (Newton metres [Nm]) and average power
(Watts) based on a mean of three repeated sets [27]. These
strength and power measures were normalised to body weight
(Nm/kg and W/kg).
Magnetic resonance imaging
All IIM patients had a thigh MRI scan using the Siemens
Magnetom Verio 3.0 T scanner (Siemens Healthcare,
Germany) powered by the syngo (MR B17) software. Axial,
coronal and sagittal images were acquired of the same side
using the MRI protocol described in Table 1 of the supple-
mentary material.
The images of the quadriceps and hamstrings muscles
were scored based on three main aspects: muscle oedema,
fatty infiltration and muscle atrophy based on previously
described methods [28–30]. Each muscle was scored as
normal, mild, moderate or severe for each feature accord-
ing to the definitions and scoring criteria explained in the
supplementary material (Table 2). This semi-quantitative
scoring was performed by two musculoskeletal radiolo-
gists experienced in reading muscle MRI (25 and 11 years
of experience). The radiologists were only aware that they
were scoring IIM patients, but were blinded to other clin-
ical, laboratory, SWE and muscle strength information.
Inter-reader reproducibility was analysed to assess scoring
agreement. Post-individual scoring, cases of disagreement
between the radiologists were reconciled by consensus.
Statistical analysis
Data analysis was performed using SPSS version 25 (IBM,
Armonk, NY, USA) and GraphPad Prism version 7.00
(GraphPad Software, La Jolla, CA, USA). Descriptive analy-
sis was performed to report the main characteristics of each
muscle elasticity and was graphically represented in box plots.
Intra-operator reproducibility of the repeated SWE measure-
ments was analysed using intraclass correlations (ICC). Inter-
reader agreement over the ordinal MRI scores was analysed
using quadratic weighted Kappa coefficients (Kw).
Independent sample Student’s t test was used to determine
if there was a significant difference in mean SWV values
between patients and healthy controls per muscle. A receiver
operating characteristic (ROC) curve and the area under ROC
(AUROC) were reported to evaluate the ability of SWE to
discriminate participants with and without IIM. Spearman’s
correlation coefficients were calculated to correlate SWVwith
CK levels, disease duration in addition to the results of the
muscle tests.
The association between SWE and MRI scores was evalu-
ated using the Jonckheere–Terpstra test to detect significant
monotonic trends between SWV and MRI scores. Kendall’s
tau-b correlation coefficients were also calculated for the two
variables. The 95% confidence intervals (CIs) were calculated
where appropriate. All tests were two-tailed. Absolute corre-
lation coefficients ≥ 0.3 and statistical significance at p < 0.05
was considered a potential effect worthy of further fully-
powered investigation.
Results
Patients and characteristics
A total of 23 patients diagnosed with IIM volunteered to par-
ticipate in this study (10 males and 13 females; mean age
[SD] = 50.4 years [16.1]). Clinical data of the recruited IIM
patients are listed in Table 1. With regard to disease activity, 4
patients had a normal level of CK, but re-presented with sig-
nificant muscle weakness and were determined as clinically
active by the physician. The patients were frequency-
matched to 23 healthy controls. The descriptive character-
istics of the patients and healthy controls are represented
and tested for differences in Table 2. Five IIM patients
failed to perform the ETGUG test, of 2 of whom also
failed to perform the knee extension/flexion due to severe
muscle weakness.
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Muscle shear wave elastography
The descriptive data for the SWV measurements are reported
in Table 3. It shows the results of the independent sample t-
test, which demonstrated a significantly lower muscle stiffness
in IIM across all the quadriceps and hamstrings in the resting
position (p < 0.05). In contrast, there was no significant differ-
ence for the BB or the quadriceps during passive stretching.
The clustered boxplots in Fig. 1 graphically represent the
SWV results for the various muscles of the two groups.
Examples of SWE images from IIM patients and comparable
controls are shown in Fig. 2. Sample size was too small to
meaningfully compare SWV between IIM subtypes.
Nevertheless, the inclusion body myositis patients showed
no significant SWV difference from the other IIM patients
(p = 0.24).
Intra-operator reproducibility showed substantial reliability
with ICC > 0.95 for all muscles except for the stretched RF,
which had a slightly lower ICC of 0.84 (Supplementary
Table 3). ROC curve for SWE was plotted in Fig. 3 using
clinical diagnosis (based on a composite of clinical assess-
ments and investigations) as the reference standard. SWE
had AUROC results demonstrating an excellent level of dis-
crimination for the quadriceps and hamstrings in the resting
position (Table 4).
Shear wave elastography correlations with clinical
variables and muscle tests
Shear wave elastography correlations with CK and disease
duration were generally weak (rs = 0.28 [p = 0.19] and rs =
0.26 [p = 0.24] respectively). However, slower walking
speeds in the ETGUG were associated with lower SWV for
the VL (rs = −0.56), VI (rs = −0.64) and RF (rs = −0.51).
Stronger grip strength was associated with higher SWV for
the VL (rs = 0.47), BF (rs = 0.62) and SM (rs = 0.45). A higher
number of chair stands correlated positively with SWV for VL
(rs = 0.51, p = 0.012). The knee strength test correlated only
Table 1 Clinical data of all idiopathic inflammatory myopathies (IIM) patients
Case
number
Sex Age
(years)
Diagnosis Disease duration
(months)
CK level
(IU/L)a
Treatment
1 Female 76.5 Undifferentiated IIM 20 601 Prednisolone
2 Male 54.7 Undifferentiated IIM 1.1 708 Methylprednisolone, prednisolone
3 Female 58.6 Overlap myositis (polymyositis and
rheumatoid arthritis)
0.2 2,662 Methylprednisolone, prednisolone
4 Female 63.0 Undifferentiated IIM 6.5 324 Methotrexate, prednisolone
5 Male 38.2 Dermatomyositis 0.5 1,375 None
6 Female 50.9 Polymyositis 2.4 1,000 Mycophenolate, prednisolone
7 Male 57.0 Polymyositis 108.7 757 Methotrexate
8 Male 40.7 Undifferentiated IIM 34.8 12,802 Methotrexate, prednisolone
9 Female 74.6 Undifferentiated IIM 2.1 777 Intravenous immunoglobulins,
prednisolone
10 Female 35.8 Polymyositis 8.1 1,205 Prednisolone, azathioprine
11 Female 59.1 Polymyositis 198.5 347 Methotrexate
12 Male 77.9 Inclusion body myositis 6.1 190 Methotrexate
13 Female 23.1 Dermatomyositis 0.4 4,553 Prednisolone
14 Female 40.5 Dermatomyositis 8.6 70 Hydroxychloroquine
15 Male 52.7 Overlap myositis (mixed connective tissue
disease and myositis)
64.3 692 Methotrexate, hydroxychloroquine
16 Female 49.1 Dermatomyositis 177.2 1,784 Mycophenolate,
hydroxychloroquine,
prednisolone
17 Male 58.4 Inclusion body myositis 19.9 399 Methotrexate
18 Female 43.6 Undifferentiated IIM 1.6 763 Methotrexate, hydroxychloroquine
19 Female 53.5 Undifferentiated IIM 26.3 72 Mycophenolate, prednisolone
20 Male 49.8 Polymyositis 44.9 1,225 Cyclophosphamide, prednisolone
21 Female 21.0 Undifferentiated IIM 31.2 33 Hydroxychloroquine
22 Male 60.5 Inclusion body myositis 0.4 1,184 None
23 Male 20.4 Polymyositis 2.1 634 Prednisolone
a Normal value is 25–200 IU/L for women and 40–320 IU/L for men
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with the BF; the correlations were explicably stronger for the
flexion movement (peak torque rs = 0.60, power rs = 0.53)
compared with the extension movement (peak torque rs =
0.47, power rs = 0.48). The full correlation results are provided
in Supplementary Table 4.
Magnetic resonance imaging
Inter-reader agreement between the two radiologists was
Balmost perfect^ for the overall MRI scoring of oedema,
fatty infiltration and atrophy, with a weighted Kappa
(95% CI) of 0.88 (0.83, 0.94), 0.88 (0.83, 0.93) and
0.83 (0.76, 0.90) respectively. The MRI results for the
consensus scores are presented in Supplementary
Table 5. The results of the consensus scores on the
Jonckheere–Terpstra test and Kendall’s tau-b correlations
for the associations between SWV and MRI were analo-
gous (Table 5). They determined a statistically significant
decreasing trend and a moderate negative correlation for
SWV with oedema and atrophy in several muscles. In
other words, higher MRI scores for oedema and atrophy
were associated with lower SWV results. Figure 4 dis-
plays an example of the decreasing SWV scores with
higher muscle oedema. However, the correlations between
SWV and fatty infiltration across all muscles were weak
(r < 0.3; p = 0.28).
Table 2 Characteristics of the study participants
Characteristic IIM patients Healthy controls Difference
(%)
95%CI of the difference p value*
Mean (%)a 95% CI Mean (%)a 95% CI
Sex 13 females
(56.5)
– 13 females
(56.5)
– – – 1.00
Age 50.4 (16.1) 43.4, 57.4 50.7 (16.2) 43.7, 57.7 −0.31 (−0.6) −9.9, 9.3 0.95
Males 51.0 (15.4) 40.0, 62.0 52.1 (16.0) 40.7, 63.6 −1.1 (−2.1) −15.8, 13.6 0.87
Females 49.9 (17.2) 39.6, 60.3 49.6 (17.0) 39.4, 59.9 0.3 (0.6) −13.5, 14.1 0.96
Height (cm) 169.0 (9.8) 164.7,
173.4
169.3 (10.5) 164.7,
173.8
−0.3 (−0.2) −6.3, 5.8 0.92
Weight (kg) 75.2 (11.2) 70.1, 80.2 72.9 (14.4) 67.0, 79.1 2.25 (3.2) −5.5, 10.0 0.56
Body mass index 26.5 (5.4) 24.2, 28.8 25.3 (3.9) 23.6, 26.9 1.25 (4.7) −1.5, 4.0 0.37
Waist–hip ratio 0.90 (0.01) 0.86, 0.94 0.86 (0.01) 0.82, 0.90 0.04 (4.7) −0.01, 0.09 0.16
Smoking 9 (39) – 12 (52) – – – 0.37
Smoking pack-years 21.0 (15.6) 9.7, 33.7 13.1 (19.6) 0.7, 25.6 8.6 (60.3) −8.0, 25.2 0.29
Drinking alcohol 8 (35) – 5 (22) – – – 0.33
Consumption (units/week) 3.7 (3.5) 0.7, 6.7 7.5 (2.5) 4.3, 10.7 −3.8 (−50.7) −7.9, 0.2 0.06
Visual analogue score (mm) 53.2 (19.0) 45.0, 61.4 11.3 (16.0) 4.4, 18.3 41.8 (370) 31.4, 52.3 <0.001
ETGUGT, sit to stand (s) 2.5 (3.0) 1.0, 3.9 1.0 (0.3) 0.9, 1.1 1.5 (150) 0.2, 2.7 <0.001
ETGUGT, gait initiation (s) 1.4 (0.9) 1.0, 1.9 0.9 (0.4) 0.7, 1.0 0.6 (55.6) 0.1, 1.0 <0.001
ETGUGT, walk 1 (s) 6.2 (1.8) 5.4, 7.1 4.3 (0.8) 3.9, 4.7 1.9 (44.2) 1.1, 2.8 <0.001
ETGUGT, turn around (s) 4.3 (1.4) 3.6, 4.9 3.0 (0.5) 2.8, 3.2 1.2 (43.3) 0.5, 2.0 0.002
ETGUGT, walk 2 (s) 6.4 (1.9) 5.4, 7.4 4.4 (0.8) 4.1, 4.7 2 (45.5) 1.0, 3.0 <0.001
ETGUGT, slow, stop (s) 4.5 (1.7) 3.7, 5.3 2.7 (0.6) 2.4, 2.9 1.8 (66.7) 0.9, 2.6 <0.001
ETGUGT, total time (s) 25.3 (9.0) 20.8, 29.8 16.2 (2.7) 15.1, 17.4 9.1 (56.2) 4.4, 13.7 <0.001
30-s chair sit-to-stands 5.1 (5.4) 2.8, 7.5 18.6 (5.2) 16.3, 20.8 −13.4 (−72.6) −16.6-10.3 <0.001
Handgrip strength (kg) 16.3 (10.4) 11.8, 20.8 37.6 (12.5) 32.0, 43.2 −21.3 (−56.6) −28.2-14.4 <0.001
Knee extension torque
(Nm/kg)
0.52 (1.02)b 0.29, 0.85 1.53 (0.70)b 1.25, 1.75 −1.01 (−66.0) −1.22, −0.53 <0.001
Knee flexion torque (Nm/kg) 0.36 (0.28)b 0.24, 0.45 0.86 (0.43)b 0.70, 0.99 −0.5 (−58.1) −0.64, −0.29 <0.001
Knee extension power (W/kg) 0.20 (0.62)b 0.06, 0.55 0.92 (0.43)b 0.72, 1.09 −0.72 (−78.3) −0.82, −0.38 <0.001
Knee flexion power (W/kg) 0.17 (0.21)b 0.10, 0.26 0.55 (0.21)b 0.47, 0.63 −0.38 (−69.1) −0.46, −0.24 <0.001
ETGUGT expanded timed get-up-and-go test
*p values significant at 95% are in italics. Continuous variables were tested via independent t test or Mann–Whitney U test, and categorical data were
tested using the Chi-squared test
a Data in parentheses represent standard deviations for means or percentages for ratio
bMedian and interquartile range (95% confidence interval for the median values is generated based on 1,000 bootstrap samples)
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Discussion
To our knowledge, this is the first case–control study to inves-
tigate muscle elasticity using SWE in IIM patients, and also
the first to study the association of SWE with muscle strength
and MRI features. The results, particularly the lower muscle
stiffness measurements in IIM during the resting position
across the lower limb muscles tested, support the face validity
of SWE. The pathological mechanisms for this include the
presence of destructive inflammatory infiltrates causing oede-
ma and muscle atrophy [13].
The diagnostic performance of SWE was strong for
discriminating IIM from healthy controls in the muscles
that showed significant differences. For the best
performing muscle (SM), there was a 92% chance of cor-
rectly distinguishing IIM from healthy muscle. But the
diagnostic performance of BB and stretched quadriceps
was not much better than a coin toss. However, it should
be noted that an extreme design such as this (health com-
pared with diagnosed IIM) cannot measure clinically rel-
evant diagnostic performance.
These exploratory muscle assessments suggest that IIM
patients lost, on average, half of their strength and functional
performance compared with healthy controls. The moderate
correlations with muscle elasticity were heterogeneous and
inconsistent across the different tests and muscles. Abnormal
Table 3 Shear wave elastography measurements of the scanned muscles for the IIM patients and healthy controls
Muscle IIM patients Healthy controls Difference 95% CI of the differenceb p value* Effect size
Mediana 95% CI Mediana 95% CI
Vastus lateralis 1.35 (0.32) 1.26, 1.44 1.68 (0.23) 1.62, 1.76 −0.33 (−19.6%) −0.42, −0.20 <0.001 1.18
Passively stretched 2.60 (0.68) 2.36, 2.93 2.65 (0.51) 2.56, 2.81 −0.05 (−1.9%) −0.31, 0.21 0.504 0.08
Rectus femoris 1.52 (0.33) 1.43, 1.65 1.81 (0.23) 1.71, 1.85 −0.29 (−16.0%) −0.32, −0.10 0.006 1.02
Passively stretched 2.23 (0.53) 2.05, 2.43 2.20 (0.36) 2.12, 2.27 0.03 (1.4%) −0.20, 0.21 0.989 0.06
Vastus medialis 1.36 (0.16) 1.33, 1.46 1.60 (0.21) 1.55, 1.74 −0.24 (−15.0%) −0.34, −0.13 0.002 1.28
Passively stretched 2.28 (0.49) 2.10, 2.48 2.39 (0.38) 2.29, 2.58 −0.11 (4.6%) −0.39, 0.03 0.091 0.25
Vastus intermedius 1.62 (0.49) 1.46, 1.82 1.86 (0.22) 1.78, 1.95 −0.24 (−12.9%) −0.42, −0.08 0.038 0.63
Passively stretched 2.37 (0.39) 2.30, 2.56 2.36 (0.28) 2.25, 2.47 0.01 (0.4%) −0.12, 0.23 0.454 0.02
Biceps brachii 1.85 (0.28) 1.72, 1.90 1.78 (0.20) 1.75, 1.90 0.07 (3.9%) −0.08, 0.14 0.509 0.28
Biceps femoris 1.30 (0.14) 1.28, 1.45 1.67 (0.20) 1.58, 1.76 −0.37 (−22.2%) −0.44, −0.26 <0.001 2.14
Semitendinosus 1.33 (0.31) 1.26, 1.40 1.66 (0.23) 1.58, 1.70 −0.33 (−19.9%) −0.42, −0.187 0.001 1.21
Semimembranosus 1.36 (0.28) 1.28, 1.51 1.71 (0.18) 1.63, 1.76 −0.35 (−20.5%) −0.44, −0.23 <0.001 1.48
*p values significant at 95% are in italics. Results are based on independent sample t test of natural log-transformed values
a Data in m/s with interquartile range (95% confidence interval for the median values are generated based on 1,000 bootstrap samples)
b The 95% confidence intervals (CIs) for the difference between the medians is calculated based the Hodges–Lehmann method [31]
Fig. 1 Clustered boxplot of shear
wave velocity (m/s) by participant
type. VL vastus lateralis, RF
rectus femoris, VM vastus
medialis, VI vastus intermedius,
BF biceps femoris, ST
semitendinosus, SM
semimembranosus, BB biceps
brachii, PS passively stretched
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resting muscle elasticity can be the precursor to the commonly
observed muscle weakness. It can be hypothesised that the
loss in muscle stiffness might limit force transmission capa-
bility and may be responsible for diminished muscle strength
and functional capacities.
Despite the significant abnormal findings, these prelimi-
nary findings indicate that the stretched muscle elasticity
was preserved and unaffected by IIM. If confirmed, there are
two explanations for this finding. First, the functional
stretching property of individual muscle fibres remains intact
in IIM [32]. Second, infiltrative inflammatory cells are known
to attack passive components, such as the extracellular matrix,
which plays a role in providing the resting passive elastic
property for muscle [33].
Our results of reduced muscle stiffness match those ob-
served by McCullough et al. in a case–control study of nine
active IIM patients using MRE, which also only observed a
statistically significant difference in stiffness during the re-
laxed resting position (p = 0.01) [14]. Overall, these trends
of altered muscle stiffness support the concept of the detri-
mental effects of IIM on muscle tissue and its biomechanical
property. Although the results can be linked primarily to the
Fig. 2 Shear wave elastography
images from three idiopathy
inflammatory myopathy (IIM)
patients compared with
comparable healthy controls’
muscles. VL vastus lateralis, SM
semimembranosus, BB biceps
brachii
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IIM pathological processes, secondary confounders and un-
derlying factors cannot be ruled out, such as drug-induced
myopathy.
Not all studies have observed a reduction in muscle elas-
ticity. On the contrary, Song et al. [16] compared affected
versus normal muscles within each IIM patient and reported
that the affected muscles had greater stiffness than adjacent
healthy muscles, as indicated by high strain ratios of strain
elastography. The discrepancy could be due to the different
elastographic modalities used in addition to the potential sam-
pling bias in the placement of the small ROI within the as-
sumed Bnearby normal muscle^ on ultrasound.
Of particular interest was the normal BB stiffness in IIM
patients, which could be attributed to the disease’s relative
predilection for the proximal lower thigh and hip girdle mus-
cles [20]. To our knowledge, only one study has been
published so far, Bachasson et al. [34] that utilised SWE in
myositis, which focused on the BB in inclusion body myositis
patients. Although their study design lacked a control group,
the researchers reported a significant but weak correlation be-
tween BB stiffness and muscle weakness (rs = 0.36, p < 0.05).
Our results indicated that MRI signs of activity (i.e. oede-
ma) and damage (i.e. atrophy) were associated with less mus-
cle stiffness in IIM on a number of the muscles investigated.
Potential underlying mechanisms include increased intra- and
extra-cellular water content in the case of oedema and loss of
myofibre contractile properties in atrophy. However, this as-
sociation is in contrast to the findings of Song et al. [16] and
Berko et al. [17], who reported no statistically significant cor-
relation using strain elastography. The technical and mechan-
ical factors of strain elastography may have limited its capa-
bility to detect the myositis-induced elasticity changes.We did
not find a significant correlation between SWV and MRI
scores of fatty infiltration, which is in contrast to previous
studies [35, 36]. This could be due to the relatively low prev-
alence of moderate/severe fatty infiltration in our sample.
Overall, the inconsistent SWE–MRI correlations across all
muscles could be explained by the variability in MRI muscle
involvement depending on IIM subtypes [37].
The failure of muscle elastography to correlate with IIM
disease activity was reported by Song et al. [16] and Berko
et al. [17]. The latter, however, used the physician’s grading of
disease activity as the measure instead of CK. On the other
hand, Botar-Jid et al. [15] demonstrated a close graphical pro-
portionality between CK and average hue values of the strain
elastography box. This was not substantiated by a statistical
test. Previous studies on MRI also failed to correlate with CK
[38]. In our study, the lack of correlation could be due to the
heterogeneous and wide range of CK values.
Regarding muscles, the VL showed a substantive differ-
ence in SWV between the groups and was associated with
Fig. 3 Receiver operating
characteristic curve for shear
wave elastography performance
in discriminating IIM and healthy
muscles
Table 4 Area under the operating characteristic results for the muscles
tested using shear wave elastography based on disease presence
Muscle AUROC 95% CI p value*
Vastus lateralis 0.865 0.754, 0.975 <0.001
Passively stretched 0.525 0.344, 0.705 0.782
Rectus femoris 0.790 0.649, 0.930 <0.001
Passively stretched 0.507 0.324, 0.689 0.940
Vastus medialis 0.822 0.689, 0.954 <0.001
Passively stretched 0.644 0.471, 0.817 0.110
Vastus intermedius 0.746 0.590, 0.901 0.005
Passively stretched 0.548 0.370, 0.725 0.560
Biceps brachii 0.532 0.359, 0.704 0.717
Biceps femoris 0.908 0.806, 1.000 <0.001
Semitendinosus 0.822 0.681, 0.963 <0.001
Semimembranosus 0.925 0.846, 1.000 <0.001
*Significant p values are in italics
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muscle strength impairment and moderate correlations with
MRI. It is a more accessible and easier muscle to scan because
of its location and size, and also does not require special po-
sitioning like the hamstrings. Therefore, we would recom-
mend that future SWE research uses VL as the most reliable
muscle to be assessed.
Our study has several limitations. The study is considered
relatively small; nevertheless, the sample size is larger than
previous studies on older modalities. The differences between
the types of myositis and the effects of the medications includ-
ing steroid and disease-modifying agents is also unknown.
Inter-reader reproducibility for SWE was not analysed owing
to the unavailability of a secondary reader. Cut-off values
were not computed to calculate sensitivity and specificity ow-
ing to the unbefitting study design and small sample size. We
did not compare SWE with grey-scale and Doppler findings,
as it is not well demonstrated in the literature and not currently
used as a routine investigation for myositis. Despite these
Table 5 The association between MRI and shear wave elastography in IIM patients
Muscle Oedema Fatty infiltration Atrophy
Vastus lateralis Monotonic trend, p value* 0.008 0.27 0.14
Correlation (p value)** −0.405**** (0.008) −0.099 (0.28) −0.181 (0.14)
Rectus femoris Monotonic trend, p value 0.26 0.42 0.33
Correlation (p value) 0.112 (0.26) −0.036 (0.42) 0.075 (0.33)
Vastus medialis Monotonic trend, p value <0.001 0.44 0.19
Correlation (p value) −0.553**** (0.001) −0.019 (0.45) −0.148 (0.19)
Vastus intermedius Monotonic trend, p value 0.40 0.07 0.32
Correlation (p value) −0.042 (0.40) −0.252 (0.07) −0.083 (0.32)
Biceps femoris Monotonic trend, p value <0.001 0.054 0.20
Correlation (p value) −0.489**** (0.002) −0.288 (0.054) −0.150 (0.20)
Semitendinosus Monotonic trend, p value 0.45 0.21 0.037
Correlation (p value) 0.022 (0.45) −0.137 (0.21) −0.312*** (0.038)
Semimembranosus Monotonic trend, p value 0.10 0.11 0.006
Correlation (p value) −0.219 (0.10) −0.212 (0.11) −0.444**** (0.006)
Significant p values are in italics
*The p value (one-sided test) of the Jonkheere–Terpstra test p value (significant at p < 0.05)
**The correlation coefficient and p value of Kendall’s tau-b correlations (significant at p < 0.05)
***Correlation is significant at the 0.05 level (two-tailed)
****Correlation is significant at the 0.01 level (two-tailed)
Fig. 4 Bar graph of the
significant decreasing monotonic
trend between muscle stiffness
and MRI oedema in the vastus
medialis
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limitations, we recruited well-matched healthy controls and
tested the correlations with strength, CK and MRI to provide
an extensive assessment of SWE for the first time.
The results indicate that SWE is a promising non-invasive
and quantitative method for detecting active IIM. The relative
cost-effectiveness and real-time data are two additional advan-
tages. Our work has revealed the common muscles affected
and the best muscle position in which to detect the changes.
SWE can be most useful in monitoring disease activity, as
several available methods, including biopsy, may not be fea-
sible on a routine basis.
Future studies should evaluate newly suspected and
treatment-naive IIM patients with SWE and then follow them
prospectively to determine first, if SWE readings predict a
future diagnosis of IIM, and second, if SWE is responsive to
treatment changes. To achieve a power of 90% (alpha 0.05),
the required sample sizes in future studies to detect 20%, 15%
and 10% SWV difference in the VL are 50, 80 and 154 par-
ticipants per group respectively.
In conclusion, thigh muscle stiffness, as quantitatively mea-
sured by SWE, appears to be lower in active IIM patients com-
pared with matched healthy controls. Reduced muscle stiffness
is likely to be associated with muscle weakness and MRI signs
of oedema and atrophy. However, the results did not correlate
with fatty infiltration or disease activity (CK level). SWE shows
promise as a non-invasive tool for the investigation of biome-
chanical changes in muscle in patients with IIM. Further studies
are needed to confirm these findings and to investigate the
responsiveness of SWE for monitoring disease activity.
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